Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox fMRI in Chronic Migraine
NCT02436499Phase 4Completed
- Sponsor
- University of Manitoba
- Start
- Jul 2015
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in chronic migraine, sponsored by University of Manitoba. Started Jul 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT02436499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02436499.